NCT04411303

Brief Summary

The goal of this project is to determine the feasibility and optimal parameters of a novel, comprehensive approach to gait training in individuals with chronic stroke. The comprehensive approach includes biofeedback-based gait training and aerobic exercise intensity-based gait training.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jun 2021

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

June 9, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2024

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2025

Completed
Last Updated

November 4, 2025

Status Verified

October 1, 2025

Enrollment Period

3.2 years

First QC Date

May 19, 2020

Last Update Submit

October 31, 2025

Conditions

Keywords

strokewalkingrehabilitationaerobic exercise

Outcome Measures

Primary Outcomes (1)

  • Interlimb Asymmetry - change in performance

    characterized as a comparison between the right and left legs of whole lower limb kinematics at heel strike; captured to quantify change in performance with biofeedback

    Measured at three timepoints of interest within each testing session: baseline and at the beginning and end of the biofeedback training; participants will complete 3 testing sessions over approximately 2 months

Secondary Outcomes (1)

  • Interlimb asymmetry - immediate retention

    Measured after biofeedback training in each testing session; participants will complete 3 testing sessions over approximately 2 months

Study Arms (2)

Reducing interlimb asymmetry with biofeedback post-stroke

EXPERIMENTAL

We will use a randomized crossover design to determine the performance and retention effects following single-day training sessions with biofeedback of three different gait variables (i.e., step length, propulsive force, and interlimb asymmetry) in 25 individuals with chronic stroke.

Behavioral: Step length biofeedbackBehavioral: Propulsive force biofeedbackBehavioral: Interlimb asymmetry biofeedback

Evaluating capacity for biofeedback use at varied intensities

EXPERIMENTAL

We will use a within-session randomized crossover design to test the capacity of persons post-stroke (second cohort; n=25) to reduce their interlimb asymmetry using the biofeedback variable found to be the most effective for the group in Aim 1 while walking in three aerobic intensity zones: low, moderate, and vigorous (30-40%, 50-60%, and 70-80% of heart rate reserve, respectively).

Behavioral: Aerobic intensity-based walking

Interventions

Participants will be provided with visual feedback of their right and left step lengths on a screen in front of a treadmill.

Reducing interlimb asymmetry with biofeedback post-stroke

Participants will be provided with real-time visual feedback of anterior-posterior ground reaction forces of the paretic limb during stance phase on a screen in front of a treadmill.

Reducing interlimb asymmetry with biofeedback post-stroke

Participants will be provided with visual feedback of stride-by-stride values of their interlimb asymmetry on a screen in front of a treadmill.

Reducing interlimb asymmetry with biofeedback post-stroke

Participants will walk at three different aerobic intensities. Aerobic intensity will be set based on target heart rate zones calculated with the Karvonen Formula. For low intensity, participants will walk at 30-40% intensity. In moderate intensity conditions, participants will walk at a 50-60% intensity level. In vigorous intensity conditions, participants will walk at an 70-80% intensity level. Aerobic intensity will be manipulated by changing walking speed.

Evaluating capacity for biofeedback use at varied intensities

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>6 months post stroke, affecting 1 hemisphere of the brain
  • Independently ambulatory (including use assistive devices)
  • Able to walk for 5 minutes without stopping
  • Demonstrates readiness for exercise based on responses to the PAR-Q+
  • Participants enrolled in Aim 2 will require medical clearance from physician to participate

You may not qualify if:

  • Damage to the pons or cerebellum on MRI or signs of cerebellar involvement
  • Damage to the basal ganglia or extrapyramidal symptoms
  • Uncontrolled hypertension (\>160/100mmHg)
  • Montreal Cognitive Assessment score \< 25
  • Orthopedic or pain conditions
  • Note\*: Pregnant women are excluded from this study to avoid any potential harm to the fetus from the harness used during treadmill walking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Southern California

Los Angeles, California, 90089, United States

Location

Related Publications (2)

  • Kettlety SA, Finley JM, Leech KA. Within-session propulsion asymmetry changes have a limited effect on gait asymmetry post-stroke. J Neuroeng Rehabil. 2025 Jan 22;22(1):9. doi: 10.1186/s12984-025-01553-8.

  • Kettlety SA, Finley JM, Leech KA. Within-session propulsion asymmetry changes have a limited effect on gait asymmetry post-stroke. Res Sq [Preprint]. 2024 Dec 23:rs.3.rs-5053605. doi: 10.21203/rs.3.rs-5053605/v1.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Kristan Leech, PT, DPT, PhD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 19, 2020

First Posted

June 2, 2020

Study Start

June 9, 2021

Primary Completion

August 14, 2024

Study Completion

December 14, 2025

Last Updated

November 4, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

All de-identified data from our research that underlie results in a publication will be made available.

Shared Documents
ANALYTIC CODE
Time Frame
Data will be available 6 months after publication.

Locations